Skip to content

Gorbly Compression Device for Use in Image-guided Procedures

Gorbly Compression Device for Use in Image-guided Procedures

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02578667
Enrollment
0
Registered
2015-10-19
Start date
2015-12-31
Completion date
2016-01-31
Last updated
2016-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm, Sepsis

Brief summary

Prospective cohort study. All patients presenting for percutaneous abdomino-pelvic soft tissue ablation, biopsy, or drainage performed under the care of Dr. Issam Kably will become part of the study population. Based on prior imaging and/or imaging at the time of the procedure, patients will fall into two groups, those for whom no compression is necessary to complete the procedure and those for whom compression may provide benefit. These would be selected based on Dr. Kably's experience as a practicing academic, fellowship-trained, and CAQ'ed interventional radiologist. The latter group would then further subdivide into those who give consent for use of the compression device and those who do not consent. Results of each group would be measured including the following: termination versus successful completion of the procedure; adverse events including bleeding or damage to surrounding structures necessitating further medical or surgical intervention.

Interventions

DEVICEGorbly Compression Device

The compression device provides a way to displace critical structures along the path from skin to target, retract excess body wall tissue, and provide mechanical stabilization in a repeatable and sustainable fashion.

Sponsors

Wallace H Coulter Center for Translational Research
CollaboratorOTHER
University of Miami
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All-comers presenting for percutaneous abdomino-pelvic soft tissue ablation, biopsy, or drainage .

Exclusion criteria

* Open surgical or traumatic abdominal wall. * Active abdominal wall infection.

Design outcomes

Primary

MeasureTime frame
The percentage of procedures (i.e., ablations, biopsies, or drainages) that are allowed successful completion.intraoperative

Secondary

MeasureTime frame
The rate of complication of bleeding or damage to the surrounding vessels or organs by use of the compression device.intraoperative

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026